Humpa, Ian Carl T.

HRN: 12-68-45  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2023
CEFUROXIME 1.5GM (VIAL)
08/24/2023
08/30/2023
IVTT
810mg
Q8h
Dengue With WS, T/C Partial Obstruction
Waiting Final Action 
08/24/2023
CEFUROXIME 1.5GM (VIAL)
08/24/2023
08/30/2023
IVTT
810mg
Q8h
Dengue With WS, T/C Partial Obstruction
Waiting Final Action 
08/27/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/27/2023
09/03/2023
IV
400mg
Q8hours
Empiric
Waiting Final Action 
08/30/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/30/2023
09/06/2023
IV
2.25grams
Every 8hours
T/C Intraabdominal Infection
Waiting Final Action 
09/02/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/02/2023
09/09/2023
IV
180mg
Q12
S/p Exlap Appendectomy
Waiting Final Action 
09/03/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
09/03/2023
09/09/2023
IVT
500mg Loading Dose Then 250mg Iv
Q24
T/c Fungal Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: